CD38 and neoplasm: CD38 is primarily expressed in lymphoid cells (which include T cells and macrophages), and it has been suggested that NAD+ released by tumor cells could suppress immune cell function directly while simultaneously enhancing tumor cell proliferation by converting NAD+ to cADPR via CD38 on local immune cells [99].